ProCE Banner Activity

NF1: Current State of Disease Understanding


Download this slideset for a concise summary of the clinical characteristics, diagnostic criteria, molecular pathology, and typical developmental timeline of neurofibromatosis type 1, from a current expert perspective.

Released: November 08, 2023



Jaishri Blakeley

Jaishri Blakeley, MD

The Marjorie Bloomberg Tiven Professor of Neurofibromatosis
Director, The Neurofibromatosis Therapeutic Acceleration Program
Director, The Johns Hopkins Comprehensive Neurofibromatosis Program
Department of Neurology, Neruo-Oncology
The Johns Hopkins School of Medicine
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This activity is supported by an educational grant from Alexion Pharmaceuticals.

Alexion Pharmaceuticals